by Pete Celano | Nov 10, 2025 | Uncategorized
Here’s what transpired at the annual AASLD The Liver Meeting® 2025 (Washington DC) for Day #3, 11/09/2025 — Key Sessions & Focus Areas The “Hepatology Associates Course, Part 1: Hepatology Associates as Leaders in Multidisciplinary Care” ran from 8:00...
by Pete Celano | Nov 9, 2025 | Uncategorized
Here’s what transpired at the annual AASLD The Liver Meeting® 2025 (Washington DC) for Day #2, 11/08/2025 — Key sessions & programs A full-day poster session ran from 8:00 a.m.–5:00 p.m. in Hall DE. Topics included diagnostics & biomarkers for...
by Pete Celano | Nov 7, 2025 | Uncategorized
Here are two key new trial-data disclosures from the annual AASLD The Liver Meeting® 2025 (Washington DC) for Day #1, 11/07/2025 — 1. Akero Therapeutics — Data from the Phase 2b “SYMMETRY” & “HARMONY” trials of Efruxifermin in MASLD/MASH Akero announced new...
by Pete Celano | Nov 4, 2025 | Uncategorized
From Baltimore, Maryland-based Healthworx (Healthworx operates at the intersection of healthcare and innovation by creating, co-creating and investing in companies that are improving healthcare quality, accessibility and affordability. As the innovation and investment...
by Pete Celano | Nov 3, 2025 | Uncategorized
Here’s a summary of the 10/25/2025 article “Systematic Mapping of Worldwide Research on Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‑Associated Steatohepatitis (MASH)” (PMID: 41137873) on global research trends...
